About
Psilocybin-based Products for Treatment of Mental Health Disorders
Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, chronic pain, and any other medical conditions for which psilocybin is known to have a positive effect.
Short Wave Pharma has begun preclinical studies related to its product for anorexia nervosa. The company’s future programs include the development of novel formulations and delivery approaches for chronic pain and neurodegenerative diseases.
Identity
| Name | Short Wave Pharma |
|---|---|
| Slug | short-wave-pharma |
| Type / kind | startup |
| Source _id | iUzNqTkX5MFBZxJMoeVdjeDaPcqpoiSVBq2JhmUaPdc47d2uMulq7q |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Ramat HaSharon |
| HQ address | Sderot Bialik 39, Ramat HaSharon, Israel |
Web & social
| Website | https://shortwavelifesciences.com |
|---|---|
| https://www.linkedin.com/company/80547283 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2CB2BB2G
Tags
mental-healthpharmaceuticalspatent-pendingdrug-delivery
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}